6-52237008-CAG-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_052872.4(IL17F):c.413_414delCT(p.Ser138fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000331 in 1,614,216 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00017 ( 1 hom. )
Consequence
IL17F
NM_052872.4 frameshift
NM_052872.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.255
Genes affected
IL17F (HGNC:16404): (interleukin 17F) The protein encoded by this gene is a cytokine that shares sequence similarity with IL17. This cytokine is expressed by activated T cells, and has been shown to stimulate the production of several other cytokines, including IL6, IL8, and CSF2/GM_CSF. This cytokine is also found to inhibit the angiogenesis of endothelial cells and induce endothelial cells to produce IL2, TGFB1/TGFB, and monocyte chemoattractant protein-1. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant 6-52237008-CAG-C is Benign according to our data. Variant chr6-52237008-CAG-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 539173.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS2
High AC in GnomAd4 at 285 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL17F | NM_052872.4 | c.413_414delCT | p.Ser138fs | frameshift_variant | 3/3 | ENST00000336123.5 | NP_443104.1 | |
IL17F | XM_011514276.1 | c.413_414delCT | p.Ser138fs | frameshift_variant | 4/4 | XP_011512578.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL17F | ENST00000336123.5 | c.413_414delCT | p.Ser138fs | frameshift_variant | 3/3 | 1 | NM_052872.4 | ENSP00000337432.4 | ||
IL17F | ENST00000478427.1 | n.597_598delCT | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
IL17F | ENST00000699946.1 | c.413_414delCT | p.Ser138fs | frameshift_variant | 4/4 | ENSP00000514702.1 |
Frequencies
GnomAD3 genomes AF: 0.00186 AC: 283AN: 152220Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
283
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000509 AC: 128AN: 251230Hom.: 1 AF XY: 0.000339 AC XY: 46AN XY: 135768
GnomAD3 exomes
AF:
AC:
128
AN:
251230
Hom.:
AF XY:
AC XY:
46
AN XY:
135768
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000171 AC: 250AN: 1461878Hom.: 1 AF XY: 0.000154 AC XY: 112AN XY: 727242
GnomAD4 exome
AF:
AC:
250
AN:
1461878
Hom.:
AF XY:
AC XY:
112
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00187 AC: 285AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.00193 AC XY: 144AN XY: 74496
GnomAD4 genome
AF:
AC:
285
AN:
152338
Hom.:
Cov.:
32
AF XY:
AC XY:
144
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jul 09, 2024 | BS1 - |
Candidiasis, familial, 6 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at